HCV NS5A inhibitors (Japan Tobacco)

N/A

Report date: 2025/01/26 19:08:06

NME

Base Information

Drug NameHCV NS5A inhibitors (Japan Tobacco)

Drug Alias NameHCV NS5A inhibitors (Japan Tobacco)

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionNonstructural protein 5A inhibitors

TargetsNonstructural protein 5A

Therapy Area/IndicationsHepatitis C

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryJapan

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesJapan Tobacco Inc

China Registration ClassN/A

Inactive CompaniesN/A

Active IndicationsHepatitis C

Inactive IndicationsN/A

ATC CodeN/A